Inhibition of in-stent stenosis by oral administration of bindarit in porcine coronary arteries

Armando Ialenti, Gianluca Grassia, Peter Gordon, Marcella Maddaluno, Maria Vittoria Di Lauro, Andrew H. Baker, Angelo Guglielmotti, Antonio Colombo, Giuseppe Biondi, Simon Kennedy, Pasquale Maffia

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Objective-: We have previously demonstrated that bindarit, a selective inhibitor of monocyte chemotactic proteins (MCPs), is effective in reducing neointimal formation in rodent models of vascular injury by reducing smooth muscle cell proliferation and migration and neointimal macrophage content, effects associated with the inhibition of MCP-1/CCL2 production. The aim of the current study was to evaluate the efficacy of bindarit on in-stent stenosis in the preclinical porcine coronary stent model. Methods and Results-: One or 2 bare metal stents (Multi-Link Vision, 3.5 mm) were deployed (1:1.2 oversize ratio) in the coronary arteries of 42 pigs (20 bindarit versus 22 controls). Bindarit (50 mg/kg per day) was administered orally from 2 days before stenting until the time of euthanasia at 7 and 28 days. Bindarit caused a significant reduction in neointimal area (39.4%, P

Original languageEnglish
Pages (from-to)2448-2454
Number of pages7
JournalArteriosclerosis, Thrombosis, and Vascular Biology
Volume31
Issue number11
DOIs
Publication statusPublished - Nov 2011

Fingerprint

Stents
Oral Administration
Coronary Vessels
Pathologic Constriction
Swine
Monocyte Chemoattractant Proteins
Euthanasia
Chemokine CCL2
Vascular System Injuries
Smooth Muscle Myocytes
Cell Movement
Rodentia
Metals
Macrophages
Cell Proliferation
Inhibition (Psychology)
bindarit

Keywords

  • bindarit
  • pharmacology
  • restenosis
  • stent

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Ialenti, A., Grassia, G., Gordon, P., Maddaluno, M., Di Lauro, M. V., Baker, A. H., ... Maffia, P. (2011). Inhibition of in-stent stenosis by oral administration of bindarit in porcine coronary arteries. Arteriosclerosis, Thrombosis, and Vascular Biology, 31(11), 2448-2454. https://doi.org/10.1161/ATVBAHA.111.230078

Inhibition of in-stent stenosis by oral administration of bindarit in porcine coronary arteries. / Ialenti, Armando; Grassia, Gianluca; Gordon, Peter; Maddaluno, Marcella; Di Lauro, Maria Vittoria; Baker, Andrew H.; Guglielmotti, Angelo; Colombo, Antonio; Biondi, Giuseppe; Kennedy, Simon; Maffia, Pasquale.

In: Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 31, No. 11, 11.2011, p. 2448-2454.

Research output: Contribution to journalArticle

Ialenti, A, Grassia, G, Gordon, P, Maddaluno, M, Di Lauro, MV, Baker, AH, Guglielmotti, A, Colombo, A, Biondi, G, Kennedy, S & Maffia, P 2011, 'Inhibition of in-stent stenosis by oral administration of bindarit in porcine coronary arteries', Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 11, pp. 2448-2454. https://doi.org/10.1161/ATVBAHA.111.230078
Ialenti, Armando ; Grassia, Gianluca ; Gordon, Peter ; Maddaluno, Marcella ; Di Lauro, Maria Vittoria ; Baker, Andrew H. ; Guglielmotti, Angelo ; Colombo, Antonio ; Biondi, Giuseppe ; Kennedy, Simon ; Maffia, Pasquale. / Inhibition of in-stent stenosis by oral administration of bindarit in porcine coronary arteries. In: Arteriosclerosis, Thrombosis, and Vascular Biology. 2011 ; Vol. 31, No. 11. pp. 2448-2454.
@article{526d632be236477c8b0397e24c9e0bb1,
title = "Inhibition of in-stent stenosis by oral administration of bindarit in porcine coronary arteries",
abstract = "Objective-: We have previously demonstrated that bindarit, a selective inhibitor of monocyte chemotactic proteins (MCPs), is effective in reducing neointimal formation in rodent models of vascular injury by reducing smooth muscle cell proliferation and migration and neointimal macrophage content, effects associated with the inhibition of MCP-1/CCL2 production. The aim of the current study was to evaluate the efficacy of bindarit on in-stent stenosis in the preclinical porcine coronary stent model. Methods and Results-: One or 2 bare metal stents (Multi-Link Vision, 3.5 mm) were deployed (1:1.2 oversize ratio) in the coronary arteries of 42 pigs (20 bindarit versus 22 controls). Bindarit (50 mg/kg per day) was administered orally from 2 days before stenting until the time of euthanasia at 7 and 28 days. Bindarit caused a significant reduction in neointimal area (39.4{\%}, P",
keywords = "bindarit, pharmacology, restenosis, stent",
author = "Armando Ialenti and Gianluca Grassia and Peter Gordon and Marcella Maddaluno and {Di Lauro}, {Maria Vittoria} and Baker, {Andrew H.} and Angelo Guglielmotti and Antonio Colombo and Giuseppe Biondi and Simon Kennedy and Pasquale Maffia",
year = "2011",
month = "11",
doi = "10.1161/ATVBAHA.111.230078",
language = "English",
volume = "31",
pages = "2448--2454",
journal = "Arteriosclerosis, Thrombosis, and Vascular Biology",
issn = "1079-5642",
publisher = "Lippincott Williams and Wilkins",
number = "11",

}

TY - JOUR

T1 - Inhibition of in-stent stenosis by oral administration of bindarit in porcine coronary arteries

AU - Ialenti, Armando

AU - Grassia, Gianluca

AU - Gordon, Peter

AU - Maddaluno, Marcella

AU - Di Lauro, Maria Vittoria

AU - Baker, Andrew H.

AU - Guglielmotti, Angelo

AU - Colombo, Antonio

AU - Biondi, Giuseppe

AU - Kennedy, Simon

AU - Maffia, Pasquale

PY - 2011/11

Y1 - 2011/11

N2 - Objective-: We have previously demonstrated that bindarit, a selective inhibitor of monocyte chemotactic proteins (MCPs), is effective in reducing neointimal formation in rodent models of vascular injury by reducing smooth muscle cell proliferation and migration and neointimal macrophage content, effects associated with the inhibition of MCP-1/CCL2 production. The aim of the current study was to evaluate the efficacy of bindarit on in-stent stenosis in the preclinical porcine coronary stent model. Methods and Results-: One or 2 bare metal stents (Multi-Link Vision, 3.5 mm) were deployed (1:1.2 oversize ratio) in the coronary arteries of 42 pigs (20 bindarit versus 22 controls). Bindarit (50 mg/kg per day) was administered orally from 2 days before stenting until the time of euthanasia at 7 and 28 days. Bindarit caused a significant reduction in neointimal area (39.4%, P

AB - Objective-: We have previously demonstrated that bindarit, a selective inhibitor of monocyte chemotactic proteins (MCPs), is effective in reducing neointimal formation in rodent models of vascular injury by reducing smooth muscle cell proliferation and migration and neointimal macrophage content, effects associated with the inhibition of MCP-1/CCL2 production. The aim of the current study was to evaluate the efficacy of bindarit on in-stent stenosis in the preclinical porcine coronary stent model. Methods and Results-: One or 2 bare metal stents (Multi-Link Vision, 3.5 mm) were deployed (1:1.2 oversize ratio) in the coronary arteries of 42 pigs (20 bindarit versus 22 controls). Bindarit (50 mg/kg per day) was administered orally from 2 days before stenting until the time of euthanasia at 7 and 28 days. Bindarit caused a significant reduction in neointimal area (39.4%, P

KW - bindarit

KW - pharmacology

KW - restenosis

KW - stent

UR - http://www.scopus.com/inward/record.url?scp=80054936616&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80054936616&partnerID=8YFLogxK

U2 - 10.1161/ATVBAHA.111.230078

DO - 10.1161/ATVBAHA.111.230078

M3 - Article

C2 - 21852559

AN - SCOPUS:80054936616

VL - 31

SP - 2448

EP - 2454

JO - Arteriosclerosis, Thrombosis, and Vascular Biology

JF - Arteriosclerosis, Thrombosis, and Vascular Biology

SN - 1079-5642

IS - 11

ER -